Find your path to Yang
76 people in our graph share verified history with Yang — schools, employers, funds. One of them is your warm intro.
David SchenkeinunlockedYang: together at Agios Pharmaceuticals (2017)
Yang: together at Agios Pharmaceuticals
×4Yang: together at Xiamen University
×5Yang: together at Delos Capital
About
Yang Cheng joined Delos in 2022 as an Associate, bringing over ten years of experience in biomedical sciences. She was previously a drug discovery researcher at Boehringer Ingelheim focused on autoimmune diseases, holds a Ph.D. in Genetics from the University of Rochester, and a B.S. in Biology from Xiamen University.
Contact· self-published, not guessed
Invests in
Biotech
Experience
- Delos CapitalAssociatecurrent2022 — presentHong Kong
- Boehringer IngelheimPostdoctoral Researcher2018 — 2022Ridgefield, Connecticut, United States
- The New York Academy of SciencesSTEM Mentor2020 — 2021
- University of RochesterPostdoctoral Researcher2018Rochester, New York Area
- University of RochesterGraduate Research Assistant2011 — 2018Rochester, New York Area
- Agios PharmaceuticalsSummer Intern2017Greater Boston Area
Skills & more
Molecular BiologyGenetics1Cell BiologyResearchProject ManagementCell CultureBiochemistry2Data AnalysisPolymerase Chain Reaction (PCR)1Western BlottingMicrosoft PowerPointMicrosoft Excel
+5 more
Microsoft OfficeCRISPRMammalian Cell CultureRNA BiologyEpigeneticsFrom Yang's professional profile.
Colleagues at Delos Capital
Adolfo Pena
Director at Delos Capital
Agnes Kwok
Financial Controller at Delos Capital
Andrea Lok
Executive Assistant at Delos Capital
Carrie Greenaway
Office Manager at Delos Capital
Dawn Griffiths
Director at Delos Capital
Eric Huang
Partner at Delos Capital
Faris Lodin
Managing Director at Sterling Equity
Hank Huang
Associate at Delos Capital
Frequently asked questions
- Who is Yang Cheng?
- Yang Cheng joined Delos in 2022 as an Associate, bringing over ten years of experience in biomedical sciences. She was previously a drug discovery researcher at Boehringer Ingelheim focused on autoimmune diseases, holds a Ph.D. in Genetics from the University of Rochester, and a B.S. in Biology from Xiamen University.
- Where does Yang Cheng work?
- Yang Cheng is Associate, Ph.D. at Delos Capital.
- What does Yang Cheng invest in?
- Yang Cheng invests in Biotech.
- Where did Yang Cheng go to school?
- Yang Cheng studied at University of Rochester (Doctor of Philosophy (Ph.D.), Genetics); Xiamen University (Bachelor of Science (B.S.), Biology/Biological Sciences).
Same school
Also attended University of Rochester156
Michael OdaiCOO & General Counsel at Mosaic VenturesCamila VieiraPartner, Head of Brazil at QED InvestorsBryan CiambellaGeneral Partner at PROOFWilliam SheahanSenior Vice President and Chief Innovation Officer at Flare Capital PartnersArtur BergmanFounder, Fastly at Amplify PartnersNicole VitulloInvestor at Arboretum Ventures
+ 150 more
Shared employers
Also worked at Boehringer Ingelheim70
Nick FutrellSenior Associate at Northpond VenturesKazuhiko NonomuraPartner at Remiges Ventures, Inc.Drew GonzalesInvestor at Side Door VenturesEmilio Erazo-FischerOperating Partner at Asabys PartnersShinobu SuzukiScientific Advisor at RDiscoveryPeter FarinaExecutive in Residence at Canaan Partners
+ 64 more
Also worked at The New York Academy of Sciences7
Elisa Torres DurneyIntern Accelerator & Venture Builder at QAI VenturesPaul M. HornExecutive Advisory Board at NYU Innovation Venture FundFarzad Abdi-DezfuliPartner Life Sciences at Sarsia Management ASLaura B. SacharManaging Partner and Co-Founder at StarVest PartnersAmalia ColangeloPrincipal at Two Bear CapitalTanner GoodePrincipal at Grain Management
+ 1 more
Also worked at University of Rochester29
Jean WeillAssociate at C4 VenturesAlan Z. LeeDirector of Investment and Finance at Excell PartnersHarshita Mira VenkateshPrincipal at Avesta FundBryan NgadiminInvestor at Altara VenturesCraig DubitskyBrain Trust at The CraftoryRonald Lee KrallSenior Advisor at Propel Bio Partners
+ 23 more
Also worked at Agios Pharmaceuticals10
David SchenkeinInvestor at GV (Google Ventures)Scott BillerInvestor at GV (Google Ventures)Brian FiskeSAB Member - Drug Development at Alix VenturesRafal PielakFounder at SOTERI SKINKate YenFounder at Auron TherapeuticsJohn EvansChief Executive Officer and Board Member at Beam Therapeutics
+ 4 more



























.jpg)















